Status: awaiting_review. Rule: atlas-profile-2.0.
8 linked publications; not a count of independent studies.
Missing appraisal does not mean no evidence exists. Inspect the full profile and source relationships in the interactive Atlas.
Historical grade: WEAK (retained from 22 September 2026; not a completed profile 2.0 assessment).
RANO-RESECT validated as prognostic in multicenter cohorts; standardizes surgical outcome reporting
Residual-tumor prognostic weight differs by molecular class; non-enhancing residual measurement is variable; supramaximal/FLAIRectomy benefit debated
Surgical trial endpoints and individual surgical goals
This is an educational research resource from Resonant Labs, not clinical advice. Atlas assessments are heuristic, not probabilities or formal GRADE ratings. Findings are summarized from the literature and may change as the field evolves.